Matches in Nanopublications for { ?s ?p "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185052.RA50bFz2w5-PPiT_uQPZUqk5j5Rh9mJ7eATweidoG1ba4130_assertion description "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185052.RA50bFz2w5-PPiT_uQPZUqk5j5Rh9mJ7eATweidoG1ba4130_provenance.
- NP272912.RADMWBpPi9qH_a3TWwzkkgBFU2v5Krgcq0Jp7p1DRl7Ls130_assertion description "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272912.RADMWBpPi9qH_a3TWwzkkgBFU2v5Krgcq0Jp7p1DRl7Ls130_provenance.
- NP367475.RAn5zsaM7Oy1Ii9K4Q2WNBhU6Bagd_cxFh_h5UTLbTKTc130_assertion description "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367475.RAn5zsaM7Oy1Ii9K4Q2WNBhU6Bagd_cxFh_h5UTLbTKTc130_provenance.
- NP309955.RAaInp9Tm24HVg-zCRMUSZUreu1g0-GLurR1pOfRKYlgQ130_assertion description "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309955.RAaInp9Tm24HVg-zCRMUSZUreu1g0-GLurR1pOfRKYlgQ130_provenance.
- NP193837.RAxy2NYPCj245rEV5e67juMpiJYLb8Wuvb97SvAHtdd14130_assertion description "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193837.RAxy2NYPCj245rEV5e67juMpiJYLb8Wuvb97SvAHtdd14130_provenance.
- NP539133.RA34vA8MTKyI1O_Ei_HSSausC2smIUUFWGOYKutR9R-AA130_assertion description "[To study the significance of AKR1C2- and AKR1C3-mediated PGD2 conversion in human prostate cell proliferation, we stably transfected androgen insensitive human prostate cancer PC-3 cells with AKR1C2 or AKR1C3 cDNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539133.RA34vA8MTKyI1O_Ei_HSSausC2smIUUFWGOYKutR9R-AA130_provenance.